Status: current, Defined. Date: 31-Oct 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1706731000168119 | pembrolizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1706741000168111 | pembrolizumab 100 mg/4 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| pembrolizumab 100 mg/4 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| pembrolizumab 100 mg/4 mL injection, vial | Is a | pembrolizumab | true | Inferred relationship | Some | ||
| pembrolizumab 100 mg/4 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| pembrolizumab 100 mg/4 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1354966581 | |
| pembrolizumab 100 mg/4 mL injection, vial | has Australian BoSS | pembrolizumab | true | Inferred relationship | Some | 1354966580 | |
| pembrolizumab 100 mg/4 mL injection, vial | has intended active ingredient | pembrolizumab | true | Inferred relationship | Some | 1354966580 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Keytruda 100 mg/4 mL injection, 4 mL vial | Is a | True | pembrolizumab 100 mg/4 mL injection, vial | Inferred relationship | Some | |
| pembrolizumab 100 mg/4 mL injection, 4 mL vial | has MPUU | True | pembrolizumab 100 mg/4 mL injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR